Intervention
Entacapone
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 9 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownEffect of Entacapone on Bodyweight Loss in Obese PopulationNCT02349243 · 2015-01-01
UNKNOWNA Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease PatientsNCT02096601 · 2014-08-11
COMPLETEDA Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease PatientsNCT01883505 · 2014-01-06
COMPLETEDThe Effect of BIA 9-1067 at Steady-state on the Levodopa PharmacokineticsNCT02170376 · 2011-09-01
COMPLETEDEfficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" PhenomenonNCT01568073 · 2011-03-01
COMPLETEDStudy of BIA 9-1067 to Investigate Its Effect on Levodopa PharmacokineticNCT01519284 · 2009-11-01
COMPLETEDAugmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATEDEntacapone Augmentation for SchizophreniaNCT00192855 · 2003-06-01
COMPLETEDAn Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesNCT00237263 · 2003-02-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED7
TERMINATED1
UNKNOWN1
Phase mix
PHASE15
PHASE24
NA1
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.